Skip to main content
. 2021 Feb 25;11:540134. doi: 10.3389/fonc.2021.540134

Figure 6.

Figure 6

Kaplan Meier plots of RFS based on midasin expression in ER+ and ER- breast cancer patients. Using Kaplan Meier Plotter, publicly available microarray repositories for breast cancer were interrogated to determine whether midasin expression was associated with different survival rates among (A) Estrogen Receptor negative (ER-) and (B) Estrogen Receptor positive (ER+) breast cancer patients. Hazard ratio (HR) and Logrank P values are shown. Low midasin expression (below median) is noted in black, and the high midasin expression (above median) is noted in red.